Algorae Pharmaceuticals Limited (1AI.AX)

0.0100 0.0000 (0.00%) At close: 10:00AM AEST

Algorae Pharmaceuticals Limited

Rialto South Tower
Level 23 525 Collins Street
Melbourne, VIC 3000
Australia
61 2 9698 5414
https://www.algoraepharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Description

Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.

Corporate governance

Algorae Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.